CD treatment partially reverts the DOL signature and reduces Plin4 expression at the mRNA and protein level arguing for a beneficial effect of targeting altered lipid metabolism in the most common form of familial ALS. The gene discussed is PLIN4; the disease is amyotrophic lateral sclerosis.